<DOC>
	<DOCNO>NCT00197366</DOCNO>
	<brief_summary>It show treatment HIV-positive woman antiretroviral medication pregnancy reduces risk HIV transmission child . However , treatment could lead selection resistant virus strain mother . The object study check HIV+ pregnant woman resistance mutation HIV antiretroviral therapy receive pregnancy . HIV-positive newborn also test , see resistant virus strain transmit mother child .</brief_summary>
	<brief_title>Development Resistance Mutations Pregnant HIV-Positive ( + ) Women Following Perinatal Antiretroviral Therapy Israel</brief_title>
	<detailed_description>The project perform collaboration Israeli National HIV Reference Center Laboratory , maintain national bank HIV-positive blood sample , HIV/AIDS treatment center locate throughout Israel . An initial survey identify retrospectively HIV+ woman give antiretroviral therapy pregnant stop treatment delivery . The list HIV+ delivery past five year participate hospital review , HIV-positive woman receive antiretroviral treatment pregnancy invite participate study project . Women currently pregnant , become pregnant study , invite participate pregnancy diagnose . After obtain informed consent , two blood sample obtain : one initiation perinatal treatment , follow delivery . ( Due technical limitation , sample viral load 1000 cp/ml genotyped . It expect HIV load rise follow cessation antiretroviral treatment , almost sample eligible resistance test . ) In addition , obtain maternal informed consent , sample newborn infect perinatally HIV also test resistance mutation , compare resistance pattern find mother . The sample obtain test genotypic resistance mutation . The result transmit treat physician assist choice antiretroviral therapy woman child , need . The data also use establish national database evaluate improve exist protocol perinatal antiretroviral treatment , use contribute international database HIV resistance . All resistance data , except give health care provider ( ) , transmit without additional identifying information .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>1 . HIVpositive woman currently pregnant past pregnancy Israel 2 . Blood/plasma sample available and/or perinatal antiretroviral treatment ( pregnancy treat ) 3 . HIV viral load sample adequate resistance testing ( approximately 1000 copies/ml ) 4 . Informed consent obtain 1 . Samples available inadequate viral load 2 . Informed consent obtain</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>pregnancy</keyword>
	<keyword>HIV-positive</keyword>
	<keyword>HIV resistance</keyword>
	<keyword>HIV</keyword>
</DOC>